von Moos, Roger <br/><br/>
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Dec 2013 
 - 3497-507 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-013-1932-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analgesics--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Breast Neoplasms--drug therapy<br/>Denosumab<br/>Diphosphonates--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Pain--prevention & control<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Quality of Life<br/>Young Adult<br/>Zoledronic Acid